InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Bernards Rene. Officer active across 1 company, notably Lixte Biotechnology Holdings, INC.. In total, 5 reports have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €59k. History available since 14 November 2022. The latest transaction was disclosed on 2 October 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Bernards Rene is a declarant linked to Lixte Biotechnology Holdings, INC. (XNAS) as Director. He has 5 filings in total, and across the 5 sampled filings between 2022-11-15 and 2023-10-05, the transactions are acquisitions, with 59449 EUR of buys and 0 EUR of sells.